Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:39296051

A clinical prognostic model related to T cells based on machine learning for predicting the prognosis and immune response of ovarian cancer.

Qiwang Lin · Weixu Ma · Mengchang Xu · Zijin Xu · Jing Wang · Zhu Liang · Lin Zhu · Menglu Wu · Jiejun Luo · Haiying Liu · Jianqiao Liu · Yunfeng Jin

Heliyon · 2024 doi:10.1016/j.heliyon.2024.e36898

Paper

complete

Experiment

partial

Data

partial

Analysis

partial

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:39296051
kind
science-record
content_hash
sha256:605eedb70772916f802a17130c32b6424e6c28acd859aee57da875b6e5361cd8
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T20:29:28Z
updated_at
2026-11-01T22:12:43Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
A clinical prognostic model related to T cells based on machine learning for predicting the prognosis and immune response of ovarian cancer.
doi
10.1016/j.heliyon.2024.e36898
pmid
39296051
authors array · 12 items
[0]
Qiwang Lin
[1]
Weixu Ma
[2]
Mengchang Xu
[3]
Zijin Xu
[4]
Jing Wang
[5]
Zhu Liang
[6]
Lin Zhu
[7]
Menglu Wu
[8]
Jiejun Luo
[9]
Haiying Liu
[10]
Jianqiao Liu
[11]
Yunfeng Jin
journal
Heliyon
year
2024
abstract
Background: Ovarian cancer (OV) is regarded as one of the most lethal malignancies affecting the female reproductive system, with individuals diagnosed with OV often facing a dismal prognosis due to resistance to chemotherapy and the presence of an immunosuppressive environment. T cells serve as a crucial mediator for immune surveillance and cancer elimination. This study aims to analyze the mechanism of T cell-associated markers in OV and create a prognostic model for clinical use in enhancing outcomes for OV patients. Methods: Based on the single-cell dataset GSE184880, this study used single-cell data analysis to identify characteristic T cell subsets. Analysis of high dimensional weighted gene co-expression network analysis (hdWGCNA) is utilized to identify crucial gene modules along with their corresponding hub genes. A grand total of 113 predictive models were formed utilizing ten distinct machine learning algorithms along with the combination of the cancer genome atlas (TCGA)-OV dataset and the GSE140082 dataset. The most dependable clinical prognostic model was created utilizing the leave one out cross validation (LOOCV) framework. The validation process for the models was achieved by conducting survival curve analysis and receiver operating characteristic (ROC) analysis. The relationship between risk scores and immune cells was explored through the utilization of the Cibersort algorithm. Additionally, an analysis of drug sensitivity was carried out to anticipate chemotherapy responses across various risk groups. The genes implicated in the model were authenticated utilizing qRT-PCR, cell viability experiments, and EdU assay. Results: This study developed a clinical prognostic model that includes ten risk genes. The results obtained from the training set of the study indicate that patients classified in the low-risk group experience a significant survival advantage compared to those in the high-risk group. The ROC analysis demonstrates that the model holds significant clinical utility. These results were verified using an independent dataset, strengthening the model's precision and dependability. The risk assessment provided by the model also serves as an independent prognostic factor for OV patients. The study also unveiled a noteworthy relationship between the risk scores calculated by the model and various immune cells, suggesting that the model may potentially serve as a valuable tool in forecasting responses to both immune therapy and chemotherapy in ovarian cancer patients. Notably, experimental evidence suggests that PFN1, one of the genes included in the model, is upregulated in human OV cell lines and has the capacity to promote cancer progression in in vitro models. Conclusion: We have created an accurate and dependable clinical prognostic model for OV capable of predicting clinical outcomes and categorizing patients. This model effectively forecasts responses to both immune therapy and chemotherapy. By regulating the immune microenvironment and targeting the key gene PFN1, it may improve the prognosis for high-risk patients.
claims array · 3 items
[0] object · 6 fields
id
claim-method
statement
Through the application of the LOOCV framework on the TCGA-OV dataset, we tested 113 different predictive models and computed the C-index for each. An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:39296051
locator
sections[20] "Construction and evaluation of a clinical prognosis model based on machine learning algorithms" paragraph 2
quote
Through the application of the LOOCV framework on the TCGA-OV dataset, we tested 113 different predictive models and computed the C-index for each. An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).
state
complete
[1] object · 6 fields
id
claim-data-access
statement
All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:39296051
locator
sections[27] "Data availability statement" paragraph 2
quote
All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).
state
complete
[2] object · 6 fields
id
claim-target-result
statement
An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).
kind
qualitative
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:39296051
locator
sections[20] "Construction and evaluation of a clinical prognosis model based on machine learning algorithms" paragraph 2
quote
An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).
state
complete
gaps array · 0 items
experiment object · 8 fields
state
partial
objective
An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:39296051
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE140082
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
blocked
blocked_on
method:group_comparison_wilcoxon
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:GSE140082
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 1 item
[0]
step:run_analysis blocked on method:group_comparison_wilcoxon
data object · 3 fields
state
partial
assets array · 3 items
[0] object · 15 fields
id
source:pmid:39296051
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.1016/j.heliyon.2024.e36898
sha256
sha256:62f42f37f81cc02943ee7f8969910880cf76e7521361e6b242c64ed51a8c54b8
bytes
45097
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.1016/j.heliyon.2024.e36898
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC11409031
source
europe_pmc_fulltext
coverage
whole_body_without_references
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:GSE140082
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE140082
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE140082
version
null
note
All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).
access_statement_kind
data_availability_statement
sample_accessions array · 380 items
[0]
GSM4153778
[1]
GSM4153779
[2]
GSM4153780
[3]
GSM4153781
[4]
GSM4153782
[5]
GSM4153783
[6]
GSM4153784
[7]
GSM4153785
[8]
GSM4153786
[9]
GSM4153787
[10]
GSM4153788
[11]
GSM4153789
[12]
GSM4153790
[13]
GSM4153791
[14]
GSM4153792
[15]
GSM4153793
[16]
GSM4153794
[17]
GSM4153795
[18]
GSM4153796
[19]
GSM4153797
[20]
GSM4153798
[21]
GSM4153799
[22]
GSM4153800
[23]
GSM4153801
[24]
GSM4153802
[25]
GSM4153803
[26]
GSM4153804
[27]
GSM4153805
[28]
GSM4153806
[29]
GSM4153807
[30]
GSM4153808
[31]
GSM4153809
[32]
GSM4153810
[33]
GSM4153811
[34]
GSM4153812
[35]
GSM4153813
[36]
GSM4153814
[37]
GSM4153815
[38]
GSM4153816
[39]
GSM4153817
[40]
GSM4153818
[41]
GSM4153819
[42]
GSM4153820
[43]
GSM4153821
[44]
GSM4153822
[45]
GSM4153823
[46]
GSM4153824
[47]
GSM4153825
[48]
GSM4153826
[49]
GSM4153827
[50]
GSM4153828
[51]
GSM4153829
[52]
GSM4153830
[53]
GSM4153831
[54]
GSM4153832
[55]
GSM4153833
[56]
GSM4153834
[57]
GSM4153835
[58]
GSM4153836
[59]
GSM4153837
[60]
GSM4153838
[61]
GSM4153839
[62]
GSM4153840
[63]
GSM4153841
[64]
GSM4153842
[65]
GSM4153843
[66]
GSM4153844
[67]
GSM4153845
[68]
GSM4153846
[69]
GSM4153847
[70]
GSM4153848
[71]
GSM4153849
[72]
GSM4153850
[73]
GSM4153851
[74]
GSM4153852
[75]
GSM4153853
[76]
GSM4153854
[77]
GSM4153855
[78]
GSM4153856
[79]
GSM4153857
[80]
GSM4153858
[81]
GSM4153859
[82]
GSM4153860
[83]
GSM4153861
[84]
GSM4153862
[85]
GSM4153863
[86]
GSM4153864
[87]
GSM4153865
[88]
GSM4153866
[89]
GSM4153867
[90]
GSM4153868
[91]
GSM4153869
[92]
GSM4153870
[93]
GSM4153871
[94]
GSM4153872
[95]
GSM4153873
[96]
GSM4153874
[97]
GSM4153875
[98]
GSM4153876
[99]
GSM4153877
[100]
GSM4153878
[101]
GSM4153879
[102]
GSM4153880
[103]
GSM4153881
[104]
GSM4153882
[105]
GSM4153883
[106]
GSM4153884
[107]
GSM4153885
[108]
GSM4153886
[109]
GSM4153887
[110]
GSM4153888
[111]
GSM4153889
[112]
GSM4153890
[113]
GSM4153891
[114]
GSM4153892
[115]
GSM4153893
[116]
GSM4153894
[117]
GSM4153895
[118]
GSM4153896
[119]
GSM4153897
[120]
GSM4153898
[121]
GSM4153899
[122]
GSM4153900
[123]
GSM4153901
[124]
GSM4153902
[125]
GSM4153903
[126]
GSM4153904
[127]
GSM4153905
[128]
GSM4153906
[129]
GSM4153907
[130]
GSM4153908
[131]
GSM4153909
[132]
GSM4153910
[133]
GSM4153911
[134]
GSM4153912
[135]
GSM4153913
[136]
GSM4153914
[137]
GSM4153915
[138]
GSM4153916
[139]
GSM4153917
[140]
GSM4153918
[141]
GSM4153919
[142]
GSM4153920
[143]
GSM4153921
[144]
GSM4153922
[145]
GSM4153923
[146]
GSM4153924
[147]
GSM4153925
[148]
GSM4153926
[149]
GSM4153927
[150]
GSM4153928
[151]
GSM4153929
[152]
GSM4153930
[153]
GSM4153931
[154]
GSM4153932
[155]
GSM4153933
[156]
GSM4153934
[157]
GSM4153935
[158]
GSM4153936
[159]
GSM4153937
[160]
GSM4153938
[161]
GSM4153939
[162]
GSM4153940
[163]
GSM4153941
[164]
GSM4153942
[165]
GSM4153943
[166]
GSM4153944
[167]
GSM4153945
[168]
GSM4153946
[169]
GSM4153947
[170]
GSM4153948
[171]
GSM4153949
[172]
GSM4153950
[173]
GSM4153951
[174]
GSM4153952
[175]
GSM4153953
[176]
GSM4153954
[177]
GSM4153955
[178]
GSM4153956
[179]
GSM4153957
[180]
GSM4153958
[181]
GSM4153959
[182]
GSM4153960
[183]
GSM4153961
[184]
GSM4153962
[185]
GSM4153963
[186]
GSM4153964
[187]
GSM4153965
[188]
GSM4153966
[189]
GSM4153967
[190]
GSM4153968
[191]
GSM4153969
[192]
GSM4153970
[193]
GSM4153971
[194]
GSM4153972
[195]
GSM4153973
[196]
GSM4153974
[197]
GSM4153975
[198]
GSM4153976
[199]
GSM4153977
[200]
GSM4153978
[201]
GSM4153979
[202]
GSM4153980
[203]
GSM4153981
[204]
GSM4153982
[205]
GSM4153983
[206]
GSM4153984
[207]
GSM4153985
[208]
GSM4153986
[209]
GSM4153987
[210]
GSM4153988
[211]
GSM4153989
[212]
GSM4153990
[213]
GSM4153991
[214]
GSM4153992
[215]
GSM4153993
[216]
GSM4153994
[217]
GSM4153995
[218]
GSM4153996
[219]
GSM4153997
[220]
GSM4153998
[221]
GSM4153999
[222]
GSM4154000
[223]
GSM4154001
[224]
GSM4154002
[225]
GSM4154003
[226]
GSM4154004
[227]
GSM4154005
[228]
GSM4154006
[229]
GSM4154007
[230]
GSM4154008
[231]
GSM4154009
[232]
GSM4154010
[233]
GSM4154011
[234]
GSM4154012
[235]
GSM4154013
[236]
GSM4154014
[237]
GSM4154015
[238]
GSM4154016
[239]
GSM4154017
[240]
GSM4154018
[241]
GSM4154019
[242]
GSM4154020
[243]
GSM4154021
[244]
GSM4154022
[245]
GSM4154023
[246]
GSM4154024
[247]
GSM4154025
[248]
GSM4154026
[249]
GSM4154027
[250]
GSM4154028
[251]
GSM4154029
[252]
GSM4154030
[253]
GSM4154031
[254]
GSM4154032
[255]
GSM4154033
[256]
GSM4154034
[257]
GSM4154035
[258]
GSM4154036
[259]
GSM4154037
[260]
GSM4154038
[261]
GSM4154039
[262]
GSM4154040
[263]
GSM4154041
[264]
GSM4154042
[265]
GSM4154043
[266]
GSM4154044
[267]
GSM4154045
[268]
GSM4154046
[269]
GSM4154047
[270]
GSM4154048
[271]
GSM4154049
[272]
GSM4154050
[273]
GSM4154051
[274]
GSM4154052
[275]
GSM4154053
[276]
GSM4154054
[277]
GSM4154055
[278]
GSM4154056
[279]
GSM4154057
[280]
GSM4154058
[281]
GSM4154059
[282]
GSM4154060
[283]
GSM4154061
[284]
GSM4154062
[285]
GSM4154063
[286]
GSM4154064
[287]
GSM4154065
[288]
GSM4154066
[289]
GSM4154067
[290]
GSM4154068
[291]
GSM4154069
[292]
GSM4154070
[293]
GSM4154071
[294]
GSM4154072
[295]
GSM4154073
[296]
GSM4154074
[297]
GSM4154075
[298]
GSM4154076
[299]
GSM4154077
[300]
GSM4154078
[301]
GSM4154079
[302]
GSM4154080
[303]
GSM4154081
[304]
GSM4154082
[305]
GSM4154083
[306]
GSM4154084
[307]
GSM4154085
[308]
GSM4154086
[309]
GSM4154087
[310]
GSM4154088
[311]
GSM4154089
[312]
GSM4154090
[313]
GSM4154091
[314]
GSM4154092
[315]
GSM4154093
[316]
GSM4154094
[317]
GSM4154095
[318]
GSM4154096
[319]
GSM4154097
[320]
GSM4154098
[321]
GSM4154099
[322]
GSM4154100
[323]
GSM4154101
[324]
GSM4154102
[325]
GSM4154103
[326]
GSM4154104
[327]
GSM4154105
[328]
GSM4154106
[329]
GSM4154107
[330]
GSM4154108
[331]
GSM4154109
[332]
GSM4154110
[333]
GSM4154111
[334]
GSM4154112
[335]
GSM4154113
[336]
GSM4154114
[337]
GSM4154115
[338]
GSM4154116
[339]
GSM4154117
[340]
GSM4154118
[341]
GSM4154119
[342]
GSM4154120
[343]
GSM4154121
[344]
GSM4154122
[345]
GSM4154123
[346]
GSM4154124
[347]
GSM4154125
[348]
GSM4154126
[349]
GSM4154127
[350]
GSM4154128
[351]
GSM4154129
[352]
GSM4154130
[353]
GSM4154131
[354]
GSM4154132
[355]
GSM4154133
[356]
GSM4154134
[357]
GSM4154135
[358]
GSM4154136
[359]
GSM4154137
[360]
GSM4154138
[361]
GSM4154139
[362]
GSM4154140
[363]
GSM4154141
[364]
GSM4154142
[365]
GSM4154143
[366]
GSM4154144
[367]
GSM4154145
[368]
GSM4154146
[369]
GSM4154147
[370]
GSM4154148
[371]
GSM4154149
[372]
GSM4154150
[373]
GSM4154151
[374]
GSM4154152
[375]
GSM4154153
[376]
GSM4154154
[377]
GSM4154155
[378]
GSM4154156
[379]
GSM4154157
sample_count
380
group_sizes
null
group_sizes_basis
null
platform
14951
taxon
Homo sapiens
title
Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes
resolution_checked_at
2026-11-01T15:39:54Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 15 fields
id
data:geo:GSE184880
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE184880
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
GSE184880
version
null
note
All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).
access_statement_kind
data_availability_statement
sample_accessions array · 12 items
[0]
GSM5599220
[1]
GSM5599221
[2]
GSM5599222
[3]
GSM5599223
[4]
GSM5599224
[5]
GSM5599225
[6]
GSM5599226
[7]
GSM5599227
[8]
GSM5599228
[9]
GSM5599229
[10]
GSM5599230
[11]
GSM5599231
sample_count
12
group_sizes
null
group_sizes_basis
null
platform
24676
taxon
Homo sapiens
title
Single-cell RNA sequencing reveals tissue architecture during human high-grade serous ovarian cancer progression
resolution_checked_at
2026-11-01T20:16:08Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
gaps array · 4 items
[0]
asset:data:geo:GSE140082 not downloaded
[1]
asset:data:geo:GSE140082 licence not read
[2]
asset:data:geo:GSE184880 not downloaded
[3]
asset:data:geo:GSE184880 licence not read
analysis object · 4 fields
state
partial
methods array · 6 items
[0] object · 10 fields
id
method-1
family
group_comparison
specific
wilcoxon
label
Group comparison
dsl_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
expressible
false
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
0.8
band
high
quote
Wilcoxon
[1] object · 10 fields
id
method-2
family
survival_analysis
specific
cox_proportional_hazards
label
Survival analysis
dsl_operations array · 1 item
[0]
cox_ph
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
time_to_event_with_censoring
evidence object · 3 fields
score
0.8
band
high
quote
Cox regression
[2] object · 10 fields
id
method-3
family
principal_component_analysis
specific
pca
label
Principal component analysis
dsl_operations array · 1 item
[0]
pca_fit
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
wide_numeric_matrix
evidence object · 3 fields
score
0.8
band
high
quote
principal component analysis
[3] object · 10 fields
id
method-4
family
correlation_analysis
specific
pearson
label
Correlation analysis
dsl_operations array · 1 item
[0]
pearson_r
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
paired_numeric_columns
evidence object · 3 fields
score
0.8
band
high
quote
Pearson correlation
[4] object · 10 fields
id
method-5
family
diagnostic_evaluation
specific
roc
label
Diagnostic test evaluation
dsl_operations array · 6 items
[0]
confusion_counts
[1]
roc_curve
[2]
sensitivity_specificity
[3]
solve_confusion_matrix
[4]
classification_metrics
[5]
published_precision_envelope
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
reference_standard_and_test
evidence object · 3 fields
score
0.7
band
medium
quote
ROC analysis
[5] object · 10 fields
id
method-6
family
null
specific
null
label
Leave-one-out cross-validation (LOOCV) with C-index-based model selection
dsl_operations array · 0 items
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 0 items
evidence object · 3 fields
score
1
band
verbatim
quote
Through the application of the LOOCV framework on the TCGA-OV dataset, we tested 113 different predictive models and computed the C-index for each. An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).
targets array · 0 items
gaps array · 2 items
[0]
method.reader_named_unmapped
[1]
method.group_comparison_wilcoxon
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
false
required_operations array · 0 items
missing_operations array · 1 item
[0]
group_comparison_wilcoxon
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 2 items
[0]
GSE140082
[1]
GSE184880
resolved_accessions array · 2 items
[0]
GSE140082
[1]
GSE184880
statements array · 1 item
[0]
All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).
basis
The paper names GSE140082, GSE184880 in GEO database and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 0 items
assets array · 2 items
[0]
source:pmid:39296051
[1]
data:geo:GSE140082
steps array · 0 items
must_build object · 5 fields
dsl_operations array · 1 item
[0] object · 3 fields
operation
group_comparison_wilcoxon
priority
null
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:GSE140082
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-11-01T19:32:13Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
5
usage object · 3 fields
prompt_tokens
12010
completion_tokens
2456
cached_tokens
264
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:39296051
type
paper
label
pmid:39296051
[1] object · 3 fields
id
source:pmid:39296051
type
manuscript
label
PMID 39296051 full text
[2] object · 3 fields
id
data:geo:GSE140082
type
dataset
label
GEO GSE140082
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:39296051
type
paper
label
pmid:39296051
[1] object · 3 fields
id
source:pmid:39296051
type
manuscript
label
PMID 39296051 full text
[2] object · 3 fields
id
data:geo:GSE140082
type
dataset
label
GEO GSE140082
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-39296051
type
extraction
used array · 1 item
[0]
source:pmid:39296051
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-GSE140082
type
accession_resolution
used array · 1 item
[0]
data:geo:GSE140082
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:39296051
parent_hash
sha256:9adab0db259de318d36363ec118df82e6ab6c5ab74c947bb402a8c68a7d686d2
fork_of
null
gaps array · 11 items
[0]
asset:data:geo:GSE140082 licence not read
[1]
asset:data:geo:GSE140082 not downloaded
[2]
asset:data:geo:GSE184880 licence not read
[3]
asset:data:geo:GSE184880 not downloaded
[4]
execution.not_run
[5]
method.group_comparison_wilcoxon
[6]
method.reader_named_unmapped
[7]
review.human_critique
[8]
review.independent_reader
[9]
review.machine_critique
[10]
step:run_analysis blocked on method:group_comparison_wilcoxon
assays array · 4 items
[0] object · 11 fields
role
data_generation
definition_id
transfection
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 3 items
[0]
for the samples. Cell culture and transient transfection The IOSE80 cell line, derived from human ova
[1]
nes was carried out in DEME F-12 medium. The transfection procedures were conducted with Lipofectamine
[2]
r, USA) using negative control (NC) and PFN1 siRNA (Sagon, China).GeneTarget sequences (5′-3′)s
order_basis
paper_text_order:4272
id
assay:1
[1] object · 11 fields
role
data_generation
definition_id
cell_culture
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.77
evidence array · 1 item
[0]
technology Co. in Beijing, China. Subsequent cultivation of these cell lines was carried out in DEME
order_basis
paper_text_order:4510
id
assay:2
[2] object · 11 fields
role
data_generation
definition_id
apoptosis_assay
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.69
evidence array · 1 item
[0]
gical pathways like EB virus infection, cell apoptosis, human cytomegalovirus infection, and the NO
order_basis
paper_text_order:5707
id
assay:3
[3] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
Wilcoxon
order_basis
consumes_earlier_output
id
assay:4
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:39296051", "kind": "science-record", "revision": 3, "content_hash": "sha256:605eedb70772916f802a17130c32b6424e6c28acd859aee57da875b6e5361cd8", "created_at": "2026-11-01T20:29:28Z", "updated_at": "2026-11-01T22:12:43Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "A clinical prognostic model related to T cells based on machine learning for predicting the prognosis and immune response of ovarian cancer.", "doi": "10.1016/j.heliyon.2024.e36898", "pmid": "39296051", "authors": ["Qiwang Lin", "Weixu Ma", "Mengchang Xu", "Zijin Xu", "Jing Wang", "Zhu Liang", "Lin Zhu", "Menglu Wu", "Jiejun Luo", "Haiying Liu", "Jianqiao Liu", "Yunfeng Jin"], "journal": "Heliyon", "year": 2024, "abstract": "Background: Ovarian cancer (OV) is regarded as one of the most lethal malignancies affecting the female reproductive system, with individuals diagnosed with OV often facing a dismal prognosis due to resistance to chemotherapy and the presence of an immunosuppressive environment. T cells serve as a crucial mediator for immune surveillance and cancer elimination. This study aims to analyze the mechanism of T cell-associated markers in OV and create a prognostic model for clinical use in enhancing outcomes for OV patients.\nMethods: Based on the single-cell dataset GSE184880, this study used single-cell data analysis to identify characteristic T cell subsets. Analysis of high dimensional weighted gene co-expression network analysis (hdWGCNA) is utilized to identify crucial gene modules along with their corresponding hub genes. A grand total of 113 predictive models were formed utilizing ten distinct machine learning algorithms along with the combination of the cancer genome atlas (TCGA)-OV dataset and the GSE140082 dataset. The most dependable clinical prognostic model was created utilizing the leave one out cross validation (LOOCV) framework. The validation process for the models was achieved by conducting survival curve analysis and receiver operating characteristic (ROC) analysis. The relationship between risk scores and immune cells was explored through the utilization of the Cibersort algorithm. Additionally, an analysis of drug sensitivity was carried out to anticipate chemotherapy responses across various risk groups. The genes implicated in the model were authenticated utilizing qRT-PCR, cell viability experiments, and EdU assay.\nResults: This study developed a clinical prognostic model that includes ten risk genes. The results obtained from the training set of the study indicate that patients classified in the low-risk group experience a significant survival advantage compared to those in the high-risk group. The ROC analysis demonstrates that the model holds significant clinical utility. These results were verified using an independent dataset, strengthening the model's precision and dependability. The risk assessment provided by the model also serves as an independent prognostic factor for OV patients. The study also unveiled a noteworthy relationship between the risk scores calculated by the model and various immune cells, suggesting that the model may potentially serve as a valuable tool in forecasting responses to both immune therapy and chemotherapy in ovarian cancer patients. Notably, experimental evidence suggests that PFN1, one of the genes included in the model, is upregulated in human OV cell lines and has the capacity to promote cancer progression in in vitro models.\nConclusion: We have created an accurate and dependable clinical prognostic model for OV capable of predicting clinical outcomes and categorizing patients. This model effectively forecasts responses to both immune therapy and chemotherapy. By regulating the immune microenvironment and targeting the key gene PFN1, it may improve the prognosis for high-risk patients.", "claims": [{"id": "claim-method", "statement": "Through the application of the LOOCV framework on the TCGA-OV dataset, we tested 113 different predictive models and computed the C-index for each. An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:39296051", "locator": "sections[20] \"Construction and evaluation of a clinical prognosis model based on machine learning algorithms\" paragraph 2", "quote": "Through the application of the LOOCV framework on the TCGA-OV dataset, we tested 113 different predictive models and computed the C-index for each. An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C)."}], "state": "complete"}, {"id": "claim-data-access", "statement": "All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:39296051", "locator": "sections[27] \"Data availability statement\" paragraph 2", "quote": "All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/)."}], "state": "complete"}, {"id": "claim-target-result", "statement": "An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).", "kind": "qualitative", "target": null, "evidence": [{"asset": "source:pmid:39296051", "locator": "sections[20] \"Construction and evaluation of a clinical prognosis model based on machine learning algorithms\" paragraph 2", "quote": "An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C)."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "partial", "objective": "An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C).", "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:39296051"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE140082"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "blocked", "blocked_on": "method:group_comparison_wilcoxon", "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:GSE140082"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": ["step:run_analysis blocked on method:group_comparison_wilcoxon"]}, "data": {"state": "partial", "assets": [{"id": "source:pmid:39296051", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.1016/j.heliyon.2024.e36898", "sha256": "sha256:62f42f37f81cc02943ee7f8969910880cf76e7521361e6b242c64ed51a8c54b8", "bytes": 45097, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.1016/j.heliyon.2024.e36898", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC11409031", "source": "europe_pmc_fulltext", "coverage": "whole_body_without_references", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:GSE140082", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE140082", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE140082", "version": null, "note": "All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM4153778", "GSM4153779", "GSM4153780", "GSM4153781", "GSM4153782", "GSM4153783", "GSM4153784", "GSM4153785", "GSM4153786", "GSM4153787", "GSM4153788", "GSM4153789", "GSM4153790", "GSM4153791", "GSM4153792", "GSM4153793", "GSM4153794", "GSM4153795", "GSM4153796", "GSM4153797", "GSM4153798", "GSM4153799", "GSM4153800", "GSM4153801", "GSM4153802", "GSM4153803", "GSM4153804", "GSM4153805", "GSM4153806", "GSM4153807", "GSM4153808", "GSM4153809", "GSM4153810", "GSM4153811", "GSM4153812", "GSM4153813", "GSM4153814", "GSM4153815", "GSM4153816", "GSM4153817", "GSM4153818", "GSM4153819", "GSM4153820", "GSM4153821", "GSM4153822", "GSM4153823", "GSM4153824", "GSM4153825", "GSM4153826", "GSM4153827", "GSM4153828", "GSM4153829", "GSM4153830", "GSM4153831", "GSM4153832", "GSM4153833", "GSM4153834", "GSM4153835", "GSM4153836", "GSM4153837", "GSM4153838", "GSM4153839", "GSM4153840", "GSM4153841", "GSM4153842", "GSM4153843", "GSM4153844", "GSM4153845", "GSM4153846", "GSM4153847", "GSM4153848", "GSM4153849", "GSM4153850", "GSM4153851", "GSM4153852", "GSM4153853", "GSM4153854", "GSM4153855", "GSM4153856", "GSM4153857", "GSM4153858", "GSM4153859", "GSM4153860", "GSM4153861", "GSM4153862", "GSM4153863", "GSM4153864", "GSM4153865", "GSM4153866", "GSM4153867", "GSM4153868", "GSM4153869", "GSM4153870", "GSM4153871", "GSM4153872", "GSM4153873", "GSM4153874", "GSM4153875", "GSM4153876", "GSM4153877", "GSM4153878", "GSM4153879", "GSM4153880", "GSM4153881", "GSM4153882", "GSM4153883", "GSM4153884", "GSM4153885", "GSM4153886", "GSM4153887", "GSM4153888", "GSM4153889", "GSM4153890", "GSM4153891", "GSM4153892", "GSM4153893", "GSM4153894", "GSM4153895", "GSM4153896", "GSM4153897", "GSM4153898", "GSM4153899", "GSM4153900", "GSM4153901", "GSM4153902", "GSM4153903", "GSM4153904", "GSM4153905", "GSM4153906", "GSM4153907", "GSM4153908", "GSM4153909", "GSM4153910", "GSM4153911", "GSM4153912", "GSM4153913", "GSM4153914", "GSM4153915", "GSM4153916", "GSM4153917", "GSM4153918", "GSM4153919", "GSM4153920", "GSM4153921", "GSM4153922", "GSM4153923", "GSM4153924", "GSM4153925", "GSM4153926", "GSM4153927", "GSM4153928", "GSM4153929", "GSM4153930", "GSM4153931", "GSM4153932", "GSM4153933", "GSM4153934", "GSM4153935", "GSM4153936", "GSM4153937", "GSM4153938", "GSM4153939", "GSM4153940", "GSM4153941", "GSM4153942", "GSM4153943", "GSM4153944", "GSM4153945", "GSM4153946", "GSM4153947", "GSM4153948", "GSM4153949", "GSM4153950", "GSM4153951", "GSM4153952", "GSM4153953", "GSM4153954", "GSM4153955", "GSM4153956", "GSM4153957", "GSM4153958", "GSM4153959", "GSM4153960", "GSM4153961", "GSM4153962", "GSM4153963", "GSM4153964", "GSM4153965", "GSM4153966", "GSM4153967", "GSM4153968", "GSM4153969", "GSM4153970", "GSM4153971", "GSM4153972", "GSM4153973", "GSM4153974", "GSM4153975", "GSM4153976", "GSM4153977", "GSM4153978", "GSM4153979", "GSM4153980", "GSM4153981", "GSM4153982", "GSM4153983", "GSM4153984", "GSM4153985", "GSM4153986", "GSM4153987", "GSM4153988", "GSM4153989", "GSM4153990", "GSM4153991", "GSM4153992", "GSM4153993", "GSM4153994", "GSM4153995", "GSM4153996", "GSM4153997", "GSM4153998", "GSM4153999", "GSM4154000", "GSM4154001", "GSM4154002", "GSM4154003", "GSM4154004", "GSM4154005", "GSM4154006", "GSM4154007", "GSM4154008", "GSM4154009", "GSM4154010", "GSM4154011", "GSM4154012", "GSM4154013", "GSM4154014", "GSM4154015", "GSM4154016", "GSM4154017", "GSM4154018", "GSM4154019", "GSM4154020", "GSM4154021", "GSM4154022", "GSM4154023", "GSM4154024", "GSM4154025", "GSM4154026", "GSM4154027", "GSM4154028", "GSM4154029", "GSM4154030", "GSM4154031", "GSM4154032", "GSM4154033", "GSM4154034", "GSM4154035", "GSM4154036", "GSM4154037", "GSM4154038", "GSM4154039", "GSM4154040", "GSM4154041", "GSM4154042", "GSM4154043", "GSM4154044", "GSM4154045", "GSM4154046", "GSM4154047", "GSM4154048", "GSM4154049", "GSM4154050", "GSM4154051", "GSM4154052", "GSM4154053", "GSM4154054", "GSM4154055", "GSM4154056", "GSM4154057", "GSM4154058", "GSM4154059", "GSM4154060", "GSM4154061", "GSM4154062", "GSM4154063", "GSM4154064", "GSM4154065", "GSM4154066", "GSM4154067", "GSM4154068", "GSM4154069", "GSM4154070", "GSM4154071", "GSM4154072", "GSM4154073", "GSM4154074", "GSM4154075", "GSM4154076", "GSM4154077", "GSM4154078", "GSM4154079", "GSM4154080", "GSM4154081", "GSM4154082", "GSM4154083", "GSM4154084", "GSM4154085", "GSM4154086", "GSM4154087", "GSM4154088", "GSM4154089", "GSM4154090", "GSM4154091", "GSM4154092", "GSM4154093", "GSM4154094", "GSM4154095", "GSM4154096", "GSM4154097", "GSM4154098", "GSM4154099", "GSM4154100", "GSM4154101", "GSM4154102", "GSM4154103", "GSM4154104", "GSM4154105", "GSM4154106", "GSM4154107", "GSM4154108", "GSM4154109", "GSM4154110", "GSM4154111", "GSM4154112", "GSM4154113", "GSM4154114", "GSM4154115", "GSM4154116", "GSM4154117", "GSM4154118", "GSM4154119", "GSM4154120", "GSM4154121", "GSM4154122", "GSM4154123", "GSM4154124", "GSM4154125", "GSM4154126", "GSM4154127", "GSM4154128", "GSM4154129", "GSM4154130", "GSM4154131", "GSM4154132", "GSM4154133", "GSM4154134", "GSM4154135", "GSM4154136", "GSM4154137", "GSM4154138", "GSM4154139", "GSM4154140", "GSM4154141", "GSM4154142", "GSM4154143", "GSM4154144", "GSM4154145", "GSM4154146", "GSM4154147", "GSM4154148", "GSM4154149", "GSM4154150", "GSM4154151", "GSM4154152", "GSM4154153", "GSM4154154", "GSM4154155", "GSM4154156", "GSM4154157"], "sample_count": 380, "group_sizes": null, "group_sizes_basis": null, "platform": "14951", "taxon": "Homo sapiens", "title": "Bevacizumab may differentially improve ovarian cancer outcome in patients with proliferative and mesenchymal molecular subtypes", "resolution_checked_at": "2026-11-01T15:39:54Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "data:geo:GSE184880", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE184880", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "GSE184880", "version": null, "note": "All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/).", "access_statement_kind": "data_availability_statement", "sample_accessions": ["GSM5599220", "GSM5599221", "GSM5599222", "GSM5599223", "GSM5599224", "GSM5599225", "GSM5599226", "GSM5599227", "GSM5599228", "GSM5599229", "GSM5599230", "GSM5599231"], "sample_count": 12, "group_sizes": null, "group_sizes_basis": null, "platform": "24676", "taxon": "Homo sapiens", "title": "Single-cell RNA sequencing reveals tissue architecture during human high-grade serous ovarian cancer progression", "resolution_checked_at": "2026-11-01T20:16:08Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}], "gaps": ["asset:data:geo:GSE140082 not downloaded", "asset:data:geo:GSE140082 licence not read", "asset:data:geo:GSE184880 not downloaded", "asset:data:geo:GSE184880 licence not read"]}, "analysis": {"state": "partial", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "wilcoxon", "label": "Group comparison", "dsl_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "expressible": false, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 0.8, "band": "high", "quote": "Wilcoxon"}}, {"id": "method-2", "family": "survival_analysis", "specific": "cox_proportional_hazards", "label": "Survival analysis", "dsl_operations": ["cox_ph"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["time_to_event_with_censoring"], "evidence": {"score": 0.8, "band": "high", "quote": "Cox regression"}}, {"id": "method-3", "family": "principal_component_analysis", "specific": "pca", "label": "Principal component analysis", "dsl_operations": ["pca_fit"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["wide_numeric_matrix"], "evidence": {"score": 0.8, "band": "high", "quote": "principal component analysis"}}, {"id": "method-4", "family": "correlation_analysis", "specific": "pearson", "label": "Correlation analysis", "dsl_operations": ["pearson_r"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["paired_numeric_columns"], "evidence": {"score": 0.8, "band": "high", "quote": "Pearson correlation"}}, {"id": "method-5", "family": "diagnostic_evaluation", "specific": "roc", "label": "Diagnostic test evaluation", "dsl_operations": ["confusion_counts", "roc_curve", "sensitivity_specificity", "solve_confusion_matrix", "classification_metrics", "published_precision_envelope"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["reference_standard_and_test"], "evidence": {"score": 0.7, "band": "medium", "quote": "ROC analysis"}}, {"id": "method-6", "family": null, "specific": null, "label": "Leave-one-out cross-validation (LOOCV) with C-index-based model selection", "dsl_operations": [], "missing_operations": [], "expressible": null, "parameters": {}, "data_shapes": [], "evidence": {"score": 1.0, "band": "verbatim", "quote": "Through the application of the LOOCV framework on the TCGA-OV dataset, we tested 113 different predictive models and computed the C-index for each. An important observation was the RSF model, which exhibited the highest C-index of 0.748 (Fig. 4C)."}}], "targets": [], "gaps": ["method.reader_named_unmapped", "method.group_comparison_wilcoxon"]}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": false, "required_operations": [], "missing_operations": ["group_comparison_wilcoxon"], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: wilcoxon."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["GSE140082", "GSE184880"], "resolved_accessions": ["GSE140082", "GSE184880"], "statements": ["All public data comes from the TCGA database (https://portal.gdc.cancer.gov) and GEO database (https://www.ncbi.nlm.nih.gov/geo/)."], "basis": "The paper names GSE140082, GSE184880 in GEO database and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": [], "assets": ["source:pmid:39296051", "data:geo:GSE140082"], "steps": []}, "must_build": {"dsl_operations": [{"operation": "group_comparison_wilcoxon", "unlocks_papers": null, "priority": null}], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:GSE140082"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-11-01T19:32:13Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 5, "usage": {"prompt_tokens": 12010, "completion_tokens": 2456, "cached_tokens": 264}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:39296051", "type": "paper", "label": "pmid:39296051"}, {"id": "source:pmid:39296051", "type": "manuscript", "label": "PMID 39296051 full text"}, {"id": "data:geo:GSE140082", "type": "dataset", "label": "GEO GSE140082"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:39296051", "type": "paper", "label": "pmid:39296051"}, {"id": "source:pmid:39296051", "type": "manuscript", "label": "PMID 39296051 full text"}, {"id": "data:geo:GSE140082", "type": "dataset", "label": "GEO GSE140082"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-39296051", "type": "extraction", "used": ["source:pmid:39296051"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-GSE140082", "type": "accession_resolution", "used": ["data:geo:GSE140082"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:39296051", "parent_hash": "sha256:9adab0db259de318d36363ec118df82e6ab6c5ab74c947bb402a8c68a7d686d2", "fork_of": null, "generation": 2}, "gaps": ["asset:data:geo:GSE140082 licence not read", "asset:data:geo:GSE140082 not downloaded", "asset:data:geo:GSE184880 licence not read", "asset:data:geo:GSE184880 not downloaded", "execution.not_run", "method.group_comparison_wilcoxon", "method.reader_named_unmapped", "review.human_critique", "review.independent_reader", "review.machine_critique", "step:run_analysis blocked on method:group_comparison_wilcoxon"], "assays": [{"role": "data_generation", "definition_id": "transfection", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["for the samples. Cell culture and transient transfection The IOSE80 cell line, derived from human ova", "nes was carried out in DEME F-12 medium. The transfection procedures were conducted with Lipofectamine", "r, USA) using negative control (NC) and PFN1 siRNA (Sagon, China).GeneTarget sequences (5′-3′)s"], "order_basis": "paper_text_order:4272", "id": "assay:1"}, {"role": "data_generation", "definition_id": "cell_culture", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.77, "evidence": ["technology Co. in Beijing, China. Subsequent cultivation of these cell lines was carried out in DEME"], "order_basis": "paper_text_order:4510", "id": "assay:2"}, {"role": "data_generation", "definition_id": "apoptosis_assay", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.69, "evidence": ["gical pathways like EB virus infection, cell apoptosis, human cytomegalovirus infection, and the NO"], "order_basis": "paper_text_order:5707", "id": "assay:3"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 0.8, "evidence": ["Wilcoxon"], "order_basis": "consumes_earlier_output", "id": "assay:4"}]}